Regulation of ATPase activity of transglutaminase 2 by MT1-MMP: Implications for mineralization of MC3T3-E1 osteoblast cultures

Journal of Cellular Physiology

Volumn 223, Issue 1, 2010, Pages 260-269

  Nakano, Yukiko ^a   Forsprecher, Jennifer ^a   Kaartinen, Mari T ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; MATRIX METALLOPROTEINASE 14; PHOSPHATE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; MINERALIZATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION;

3T3 CELLS; ADENOSINE TRIPHOSPHATE; ANIMALS; BINDING SITES; CALCIFICATION, PHYSIOLOGIC; CALCIUM; ENZYME ACTIVATION; GTP-BINDING PROTEINS; MATRIX METALLOPROTEINASE 14; MICE; MOLECULAR WEIGHT; OSTEOBLASTS; PEPTIDE FRAGMENTS; PHOSPHATES; PROTEIN PROCESSING, POST-TRANSLATIONAL; TIME FACTORS; TRANSGLUTAMINASES;

EID: 75749134894     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22034     Document Type: Article

References (93)

1. Achyuthan KE, Greenberg CS. 1987. Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem 262:1901-1906.
2. Addison WN, Azari F, Sorensen ES, Kaartinen MT, McKee MD. 2007. Pyrophosphate inhibits mineralization of osteoblast cultures by binding tomineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem 282:15872-15883.
3. Agah A, Kyriakides TR, Bornstein P. 2005. Proteolysis of cell-surface tissue transglutaminase by matrix metalloproteinase-2 contributes to the adhesive defect andmatrix abnormalities in thrombospondin-2-null fibroblasts and mice. Am J Pathol 167:81-88.
4. Al-Jallad HF, Nakano Y, Chen JL, McMillan E, Lefebvre C, Kaartinen MT. 2006. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures. Matrix Biol 25:135-148.
5. Anderson HC. 2007. The role of matrix vesicles in physiological and pathological calcification. Curr Opin Orthop 18:428-433.
6. Anderson HC, Hsu HH, Morris DC, Fedde KN, Whyte MP. 1997. Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol 151:1555-1561.
7. Anderson HC, Sipe JB, Hessle L, Dhanyamraju R, Atti E, Camacho NP, Millan JL. 2004. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 164:841-847.
8. Bartolome RA, Galvez BG, Longo N, Baleux F, van Muijen GNP, Sanchez-Mateos P, Arroyo AG, Teixido J. 2004. Stromal cell-derived factor-1a promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and rho GTPase activities. Cancer Res 64:2534-2543.
9. Beertsen W, Vanden Bos T, Everts V. 1999. Root development in mice lacking functional tissue non-specific alkaline phosphatase gene: inhibition of acellular cementum formation. J Dent Res 78:1221-1229.
10. Begg GE, Carrington L, Stokes PH, Matthews JM, Wouters MA, Husain A, Lorand L, Iismaa SE, Graham RM. 2006a. Mechanism of allosteric regulation of transglutaminase 2 by GTP. Proc Natl Acad Sci USA 103:19683-19688.
11. Begg GE, Holman SR, Stokes PH, Matthews JM, Graham RM, Iismaa SE. 2006b. Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular crosslinking activity. J Biol Chem 281:12603-12609.
12. Belkin AM, Akimov SS, Zaritskaya LS, Ratnikov BI, Deryugina EI, Strongin AY. 2001. Matrixdependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 276:18415-18422.
13. Belkin AM, Zemskov EA, Hang J, Akimov SS, Sikora S, Strongin AY. 2004. Cell-surfaceassociated tissue transglutaminase is a target of MMP-2 proteolysis. Biochemistry (Mosc) 43:11760-11769.
14. Bellows CG, Heersche JN, Aubin JE. 1992. Inorganic phosphate added exogenously or released from beta-glycerophosphate initiates mineralization of osteoid nodules in vitro. Bone Miner 17:15-29.
15. Bergamini CM. 1988. GTP modulates calcium binding and cation-induced conformational changes in erythrocyte transglutaminase. FEBS Lett 239:255-258.
16. Bergamini CM, Signorini M. 1993. Studies on tissue transglutaminases: interaction of erythrocyte type-2 transglutaminase with GTP. Biochem J 291:37-39.
17. Bonucci E. 1967. Fine structure of early cartilage calcification. J Ultrastruct Res 20:33-50.
18. Bonucci E, Silvestrini G, Bianco P. 1992. Extracellular alkaline phosphatase activity in mineralizing matrices of cartilage and bone: ultrastructural localization using a ceriumbased method. Histochemistry 97:323-327.
19. Casadio R, Polverini E, Mariani P, Spinozzi F, Carsughi F, Fontana A, Polverino de Laureto P, Matteucci G, Bergamini CM. 1999. The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur J Biochem 262:672-679.
20. Cheng PT, Pritzker KP. 1983. Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions. J Rheumatol 10:769-777.
21. Faverman L, Mikhaylova L, Malmquist J, Nurminskaya M. 2008. Extracellular transglutaminase 2 activates [beta]-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett 582:1552-1557.
22. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millan JL, MacGregor GR, Whyte MP. 1999. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14:2015-2026.
23. Filanti C, Dickson GR, Di Martino D, Ulivi V, Sanguineti C, Romano P, Palermo C, Manduca P. 2000. The expression ofmetalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis;1; in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14. J Bone Miner Res 15:2154-2168.
24. Galvez BG, Matias-Roman S, Yanez-Mo M, Sanchez-Madrid F, Arroyo AG. 2002. ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J Cell Biol 159:509-521.
25. Garimella R, Bi X, Anderson HC, Camacho NP. 2006. Nature of phosphate substrate as a major determinant of mineral type formed in matrix vesicle-mediated in vitro mineralization: an FTIR imaging study. Bone 38:811-817.
26. Gentile V, Saydak M, Chiocca EA, Akande O, Birckbichler PJ, Lee KN, Stein JP, Davies PJ. 1991. Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem 266:478-483.
27. Goding JW, Terkeltaub R, Maurice M, Deterre P, Sali A, Belli SI. 1998. Ectophosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family. Immunol Rev 161:11-26.
28. Hakim FT, Cranley R, Brown KS, Eanes ED, Harne L, Oppenheim JJ. 1984. Hereditary joint disorder in progressive ankylosis (ank/ank) mice. I. Association of calcium hydroxyapatite deposition with inflammatory arthropathy. Arthritis Rheum 27:1411-1420.
29. Heinkel D, Gohr CM, Uzuki M, Rosenthal AK. 2004. Transglutaminase contributes to CPPD crystal formation in osteoarthritis. Front Biosci 9:3257-3261.
30. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL. 2002. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 99:9445-9449.
31. Ho AM, Johnson MD, Kingsley DM. 2000. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289:265-270.
32. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92.
33. Iismaa SE, Chung L, Wu MJ, Teller DC, Yee VC, Graham RM. 1997. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP. Biochemistry (Mosc) 36:11655-11664.
34. Iismaa SE, Wu MJ, Nanda N, Church WB, Graham RM. 2000.GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket. J Biol Chem 275:18259-18265.
35. Iismaa SE, Mearns BM, Lorand L, Graham RM. 2009. Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 89:991-1023.
36. Im MJ, Graham RM. 1990. A novel guanine nucleotide-binding protein coupled to the alpha 1-adrenergic receptor. I. Identification by photolabeling or membrane and ternary complex preparation. J Biol Chem 265:18944-18951.
37. Im MJ, Russell MA, Feng JF. 1997. Transglutaminase II: a new class of GTP-binding proteinwith new biological functions. Cell Signal 9:477-482.
38. Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y. 1996. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 56:2707-2710.
39. Johnson KA, Terkeltaub RA. 2005. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. J Biol Chem 280:15004-15012.
40. Johnson K, Moffa A, Chen Y, Pritzker K, Goding J, Terkeltaub R. 1999. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Miner Res 14:883-892.
41. Johnson KA, Rose DM, Terkeltaub RA. 2008. Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation. J Cell Sci 121:2256-2264.
42. Johnson KA, van Etten D, Nanda N, Graham RM, Terkeltaub RA. 2003. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy. J Biol Chem 278:18824-18832.
43. Kaartinen MT, El-Maadawy S, Rasanen NH, McKee MD. 2002. Tissue transglutaminase and its substrates in bone. J Bone Miner Res 17:2161-2173.
44. Kaartinen MT, Sun W, Kaipatur N, McKee MD. 2005. Transglutaminase crosslinking of SIBLING proteins in teeth. J Dent Res 84:607-612.
45. Kaartinen MT, Murshed M, Karsenty G, McKee MD. 2007. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. J Histochem Cytochem 55:375-386.
46. Kirsch T. 2006. Determinants of pathological mineralization. Curr Opin Rheumatol 18:174-180.
47. Kirsch T. 2007. Physiological and pathological mineralization: a complex multifactorial process. Curr Opin Orthop 18:425-427.
48. Lafleur MA, Handsley MM, Edwards DR. 2003. Metalloproteinases and their inhibitors in angiogenesis. Expert Rev Mol Med 5:1-39.
49. Lai TS, Slaughter TF, Koropchak CM, Haroon ZA, Greenberg CS. 1996. C-terminal deletion of human tissue transglutaminase enhances magnesium-dependent GTP/ATPase activity. J Biol Chem 271:31191-31195.
50. Lai TS, Slaughter TF, Peoples KA, Hettasch JM, Greenberg CS. 1998. Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J Biol Chem 273:1776-1781.
51. Lee KN, Birckbichler PJ, Patterson MK Jr. 1989. GTP hydrolysis by guinea pig liver transglutaminase. Biochem Biophys Res Commun 162:1370-1375.
52. Lehti K, Valtanen H, Wickstrom SA, Lohi J, Keski-Oja J. 2000. Regulation ofmembrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem 275:15006-15013.
53. Liu S, Cerione RA, Clardy J. 2002. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci USA 99:2743-2747.
54. Lorand L, Graham RM. 2003. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4:140-156.
55. Manduca P, Castagnino A, Lombardini D, Marchisio S, Soldano S, Ulivi V, Zanotti S, Garbi C, Ferrari N, Palmieri D. 2009. Role of MT1-MMP in the osteogenic differentiation. Bone 44:251-265.
56. Matsuzawa T, Anderson HC. 1971. Phosphatases of epiphyseal cartilage studied by electron microscopic cytochemical methods. J Histochem Cytochem 19:801-808.
57. McKee MD, Addison WN, Kaartinen MT. 2005. Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton. Cells Tissues Organs 181:176-188.
58. Mizutani A, Sugiyama I, Kuno E, Matsunaga S, Tsukagoshi N. 2001. Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells. J Bone Miner Res 16:2043-2049.
59. Moursi AM, Damsky CH, Lull J, Zimmerman D, Doty SB, Aota S, Globus RK. 1996. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 109:1369-1380.
60. Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G. 2005. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19:1093-1104.
61. Nakano Y, Addison WN, Kaartinen MT. 2007a. ATP-mediated mineralization of MC3T3-E1 osteoblast cultures. Bone 41:549-561.
62. Nakano Y, Al-Jallad HF, Mousa A, Kaartinen MT. 2007b. Expression and localization of plasma transglutaminase factor XIIIA in bone. J Histochem Cytochem 55:675-685.
63. Narisawa S, Frohlander N, Millan JL. 1997. Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208:432-446.
64. Nurminskaya M, Kaartinen MT. 2006. Transglutaminases in mineralized tissues. Front Biosci 11:1591-1606.
65. Nurminskaya MV, Linsenmayer TF. 2002. Immunohistological analysis of transglutaminase factor XIIIA expression in mouse embryonic growth plate. J Orthop Res 20:575-578.
66. Nurminskaya M, Magee C, Faverman L, Linsenmayer TF. 2003. Chondrocyte-derived transglutaminase promotes maturation of preosteoblasts in periosteal bone. Dev Biol 263:139-152.
67. Orlandi A, Oliva F, Taurisano G, Candi E, Di Lascio A, Melino G, Spagnoli LG, Tarantino U. 2009. Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis. Amino Acids 36:755-763.
68. Pei D. 1999a. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem 274:8925-8932.
69. Pei D. 1999b. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell Res 9:291-303.
70. Pinkas DM, Strop P, Brunger AT, Khosla C. 2007. Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 5:e327.
71. Puente XS, Pendas AM, Llano E, Velasco G, Lopez-Otin C. 1996. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56:944-949.
72. Rosenthal AK, Masuda I, Gohr CM, Derfus BA, Le M. 2001. The transglutaminase, Factor XIIIA, is present in articular chondrocytes. Osteoarthritis Cartilage 9:578-581.
73. Ruangpanit N, Price JT, Holmbeck K, Birkedal-Hansen H, Guenzler V, Huang X, Chan D, Bateman JF, Thompson EW. 2002. MT1-MMP-dependent and -independent regulation of gelatinase A activation in long-term, ascorbate-treated fibroblast cultures: regulation by fibrillar collagen. Exp Cell Res 272:109-118.
74. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65.
75. Seiki M. 1999. Membrane-type matrix metalloproteinases. APMIS 107:137-143.
76. Smith AJ. 1982. A biochemical study of alkaline phosphatase isolated from rabbit incisor dentine. Arch Oral Biol 27:1081-1086.
77. Solan JL, Deftos LJ, Goding JW, Terkeltaub RA. 1996. Expression of the nucleoside triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by activation of the protein kinase A and C pathways in osteoblastlike osteosarcoma cells. J Bone Miner Res 11:183-192.
78. Takeuchi Y, Birckbichler PJ, Patterson MK Jr, Lee KN. 1992. Putative nucleotide binding sites of guinea pig liver transglutaminase. FEBS Lett 307:177-180.
79. Takeuchi Y, Birckbichler PJ, Patterson MKJr, Lee KN, Carter HA. 1994. Calmodulin regulates nucleotide hydrolysis activity of tissue transglutaminase. Z Naturforsch [C] 49:453-457.
80. Takino T, Sato H, Shinagawa A, Seiki M. 1995. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MTMMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 270:23013-23020.
81. Tesch W, Vandenbos T, Roschgr P, Fratzl-Zelman N, Klaushofer K, Beertsen W, Fratzl P. 2003. Orientation of mineral crystallites and mineral density during skeletal development in mice deficient in tissue nonspecific alkaline phosphatase. J Bone Miner Res 18:117-125.
82. Thouverey C, Bechkoff G, Pikula S, Buchet R. 2009. Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition bymatrix vesicles. Osteoarthritis Cartilage 17:64-72.
83. Toth M, Hernandez-Barrantes S, Osenkowski P, Bernardo MM, Gervasi DC, Shimura Y, Meroueh O, Kotra LP, Galvez BG, Arroyo AG, Mobashery S, Fridman R. 2002. Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme. J Biol Chem 277:26340-26350.
84. van de Lest CH, Vaandrager AB. 2007. Mechanism of cell- mediatedmineralization. Curr Opin Orthop 18:434-443.
85. Wang D, Canaff L, Davidson D, Corluka A, Liu H, Hendy GN, Henderson JE. 2001. Alterations in the sensing and transport of phosphate and calcium by differentiating chondrocytes. J Biol Chem 276:33995-34005.
86. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT. 1999. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14:893-903.
87. Watson LP, Kang YH, Falk MC. 1989. Cytochemical properties of osteoblast cell membrane domains. J Histochem Cytochem 37:1235-1246.
88. Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP, MacGregor GR. 1995. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 11:45-51.
89. Whyte MP. 1994. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15:439-461.
90. Whyte MP, Landt M, Ryan LM, Mulivor RA, Henthorn PS, Fedde KN, Mahuren JD, Coburn SP. 1995. Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 50-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy. J Clin Invest 95:1440-1445.
91. Will H, Hinzmann B. 1995. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231:602-608.
92. Yoshiko Y, Candeliere GA, Maeda N, Aubin JE. 2007. Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol Cell Biol 27:4465-4474.
93. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Cao Y, Tryggvason K. 2000. Impaired endochondral ossification and angiogenesis in mice deficient in membranetype matrix metalloproteinase I. Proc Natl Acad Sci USA 97:4052-4057.